Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cork

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Dermatology (Basel, Switzerland)|August 10, 2005
Consensus statement on the safety profile of topical calcineurin inhibitorsT Bieber, M Cork, C Ellis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2019
European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation periodC Vestergaard, A Wollenberg, S Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2021
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external expertsJ Ring, M Worm, A Wollenberg, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Dermatology (Basel, Switzerland)|August 10, 2005
Consensus statement on the safety profile of topical calcineurin inhibitorsT Bieber, M Cork, C Ellis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 25, 2019
European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation periodC Vestergaard, A Wollenberg, S Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2021
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external expertsJ Ring, M Worm, A Wollenberg, et al.
Pageof 3